Parkinsons Disease Related Content

Yesterday on World Parkinson's Day in the Journal of Parkinson's Disease, researchers revealed the potential environmental origins of Parkinson's disease.

We spoke with Parkinson’s UK, an organisation dedicated to funding important research and supporting those affected by Parkinson’s, about the prevalence, impact, and management of the condition.

A group of researchers around the globe have created a portable, non-invasive device capable of identifying biomarkers associated with Alzheimer's and Parkinson's disease.

Herantis Pharma is an innovative biotech company developing disease-modifying therapies for Parkinson’s disease.

A team of neuroscientists, neurosurgeons and engineers have created a speech prosthesis that can interoperate a person's brain signals and convert them into speech.

In 1980, hundreds of individuals reported to emergency clinics in Northern California complaining of tremors, motility problems, and mild cognitive deficits - all classic signs of Parkinson’s disease (PD)

In an interview with Clair Mace, examined what the Personal KinetiGraph can really do for patients dealing with Parkinson’s disease.

In a groundbreaking collaboration, the Accelerated Capability Environment (ACE) has teamed up with the NHS's AI Skunkworks to harness AI to diagnose Parkinsons with unprecedented speed.

Digital health platforms offer vast potential for enhancing the lives of PD patients and caregivers. A study in the Journal of Nutrition Education and Behavior emphasises their role in improving healthcare services.

Parkinson’s Disease affects all activities of patient daily living but PKG can help.

A Parkinson's watch is being given to patients with the condition, in an effort to improve NHS remote monitoring.

Research shows that a new form of non-invasive brain surgery using a focused form of ultrasound will prove invaluable for with Parkinson’s symptoms.

The death rate from Parkinson’s disease has risen by 63% in the United States, according to a new study.

Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.

Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.

Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?

A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease

National Institutes of Health scientists develop new brain disease test for the early diagnosis of Parkinson’s disease and dementia with Lewy bodies The group, led by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), tested 60 cerebral spinal fluid samples, including 12 from people with Parkinson’s disease, 17 from...

Table Tennis Scotland awarded £45,000 to become dementia friendly Table Tennis Scotland is receiving £35,000 from the Life Changes Trust and £10,000 from Sportscotland to become dementia friendly. Table Tennis Scotland successfully ran two pilot projects in Dundee and Haddington for over 50's with dementia and Parkinson's disease. As a result, they are now...

The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s My PD Journey is a multi-stakeholder European coalition led by the European Parkinson’s Disease Association (EPDA) and it is a positive development in terms of the positive progress being made for...